I joined Dana-Farber Brigham Cancer Center (DFBCC) and the faculty at Harvard Medical School on October 1, 2010. I currently serve as the Chair of Radiation Oncology for the Dana-Farber Cancer Institute (DFCI) where I serve the institution to shape and guide the future of cancer care as we build the DFCI Inpatient Hospital.
My area of excellence is the clinical expertise and innovation of genitourinary radiation oncology. I continue to explore innovations in the field of brachytherapy and lead a thriving prostate brachytherapy program, which attracts physicians from around the world to observe and learn. These programs utilize advanced treatment planning and radioactive isotope delivery systems providing high quality outcomes with decreased side effects. During my tenure at DFBCC, I have had the opportunity to provide hands-on instruction to urologists, radiation oncology residents, urology fellows and attending physicians locally, nationally and internationally.
I am regularly invited to provide and moderate lectures locally, nationally and internationally on prostate cancer. I serve on the faculty of both ABS and ASTRO, where I provide educational lectures to the membership. I continue to publish on the topic of prostate cancer and prostate brachytherapy in peer reviewed journals. I serve as an ad-hoc reviewer for several journals, I am a co-editor for genitourinary malignancies for the Journal of Contemporary Brachytherapy and Associate Editor for the Genitourinary Section of Brachytherapy.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none